Priority Date: 05.12.11 (US 201161566912P)

ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3) DIRECTED TO DOMAIN III AND DOMAIN IV OF HER3

  • Application ID: EP12816130
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in C07. Novartis Pharma AG, Novartis Pharma AG is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 05.12.2011 - Priority Date (US 201161566912P)
  • 13.06.2013 - Publication A2 (WO2013084151)
  • 15.10.2014 - Publication A2 (EP2788381)

IPC Classification